ArticleHealth science reports2024

Experiences in the use of multiple doses of convalescent plasma in critically ill patients with COVID-19: An early phase 1 descriptive study.

Ricardo Aguilar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.